Sentinel Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sentinel Asset Management's BMY Position: Q4 2017 in Review
Sentinel Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 405,300 shares — an estimated $25.8M sold.
Sentinel Asset Management first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $36.6M in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Sentinel Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
- Sentinel Asset Management sold 405,300 Bristol-Myers Squibb shares in Q4 2017, an estimated $25.8M.
- Sentinel Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
- Sentinel Asset Management's Bristol-Myers Squibb position peaked at $36.6M in Q2 2016.
- 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.